Allevorin interleukin-3: Filed for Canadian permission to start a Phase I/II trial

Cangene Corp. (TSE:CNJ), Toronto Product: Allevorin interleukin-3, which stimulates blood cell precursors Indication: Enhance marrow recovery after therapies for metastatic breast cancer, eventually i...